Följ
Alexandre de Titta, PhD
Alexandre de Titta, PhD
Bioengineer
Verifierad e-postadress på alumni.epfl.ch
Titel
Citeras av
Citeras av
År
Binding of silver nanoparticles to bacterial proteins depends on surface modifications and inhibits enzymatic activity
NS Wigginton, A de Titta, F Piccapietra, J Dobias, VJ Nesatyy, MJF Suter, ...
Environmental science & technology 44 (6), 2163-2168, 2010
3202010
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
A de Titta, M Ballester, Z Julier, C Nembrini, L Jeanbart, AJ van der Vlies, ...
Proceedings of the National Academy of Sciences 110 (49), 19902-19907, 2013
2932013
Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes
L Jeanbart, M Ballester, A de Titta, P Corthésy, P Romero, JA Hubbell, ...
Cancer immunology research 2 (5), 436-447, 2014
1922014
Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses
DJ Dowling, EA Scott, A Scheid, I Bergelson, S Joshi, C Pietrasanta, ...
Journal of Allergy and Clinical Immunology 140 (5), 1339-1350, 2017
1522017
Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice
IC Kourtis, S Hirosue, A De Titta, S Kontos, T Stegmann, JA Hubbell, ...
PloS one 8 (4), e61646, 2013
1422013
Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis
M Ballester, C Nembrini, N Dhar, A de Titta, C De Piano, M Pasquier, ...
Vaccine 29 (40), 6959-6966, 2011
1322011
Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice
M Ballester, L Jeanbart, A de Titta, C Nembrini, BJ Marsland, JA Hubbell, ...
Scientific reports 5, 14274, 2015
492015
The TLR4 Agonist Fibronectin Extra Domain A is Cryptic, Exposed by Elastase-2; use in a fibrin matrix cancer vaccine
Z Julier, MM Martino, A de Titta, L Jeanbart, JA Hubbell
Scientific reports 5, 2015
492015
Engineering targeting materials for therapeutic cancer vaccines
PS Briquez, S Hauert, A de Titta, LT Gray, AT Alpar, MA Swartz, ...
Frontiers in bioengineering and biotechnology 8, 19, 2020
232020
Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses
Z Julier, A de Titta, AJ Grimm, E Simeoni, MA Swartz, JA Hubbell
Vaccine 34 (21), 2453-2459, 2016
212016
Phenology of Passerine bird migration in the Danube Delta, Romania
B Droz, S Joye, A de Titta, F Schneider, S Antoniazza
The Ring 38 (1), 25-42, 2016
52016
Adjuvant-free immunization with infective filarial larvae as lymphatic homing antigen carriers
C Card, DS Wilson, S Hirosue, M Rincon-Restrepo, A de Titta, E Güç, ...
Scientific reports 10 (1), 1055, 2020
12020
Reflets des résultats du camp international de baguage du Groupe des Jeunes de Nos Oiseaux dans le delta du Danube en 2007-2008
B Droz, A de Titta, F Schneider, S Antoniazza
Nos Oiseaux 1 (527), 64, 2017
2017
Dianhydrohexitol codrug
A DE TITTA, G De Visscher, M Takeiri, N Schüwer
2016
Compounds and formulations for the treatment of wounds
G De Visscher, W Eevers, N Schüwer, T Shigematsu, M Takeiri, ...
2016
Development of an extracellular matrix (ECM)-mimetic nanoparticle-based platform to deliver growth factors for inner ear regeneration
PS Briquez, A de Titta, C Takeda, JA Hubbell
Swiss Society for Biomaterials and Regenerative Medicine Annual Meeting 30 (S1), 2015
2015
Materials and protein engineering approaches for modulating immunity
J Hubbell, M Swartz, M Ballester, A de Titta, L Jeanbart, S Kontos, ...
Abstracts Of Papers Of The American Chemical Society 247 (EPFL-CONF-207222), 2014
2014
Engineering adjuvants for prophylactic and therapeutic subunit vaccines
A de Titta
EPFL, 2014
2014
Mechanisms of protein adhesion to bare and carbonate-coated silver nanoparticles
NS Wigginton, A de Titta, VJ Nesatyy, MJF Suter, R Bernier-Latmani
Geochimica et Cosmochimica Acta 73 (EML-CONF-2009-019), A1441, 2009
2009
Evaluating the use of nanoparticles as an antigen delivery system
A de Titta, M Tamborini, MA Swartz, G Pluschke, JA Hubbell
2008
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20